Literature DB >> 3585557

Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats.

K Muramatsu, M Fukuyo, Y Hara.   

Abstract

Effects of tea catechins (tannins) on lipid metabolism were studied in male weanling rats fed a 25% casein diet containing 15% lard and 1% cholesterol for 28 days. Crude tea catechins prepared from green tea powder were supplemented at a 1% and 2% of the lard-cholesterol diet. The addition of 2% tea catechins slightly depressed growth but at the 1% level was without effect. Tea catechins decreased plasma total cholesterol, cholesterol ester, total cholesterol--HDL-cholesterol (VIDL-+LDL-cholesterol) and atherogenic index (VLDL-+LDL-cholesterol/HDL-cholesterol). Hematocrit and plasma glucose were not altered by the addition of tea catechins. The liver weight, liver total lipids and cholesterol concentrations in rats fed the lard-cholesterol diet increased more than in the control rats, but the addition of tea catechins to the lard-cholesterol diet decreased those parameters. Tea catechin supplementation increased fecal excretion of total lipids and cholesterol. The results demonstrate that tea catechins exert a hypocholesterolemic effect in cholesterol-fed rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3585557     DOI: 10.3177/jnsv.32.613

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  33 in total

1.  Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes.

Authors:  Marcela A Vazquez Prieto; Ahmed Bettaieb; Cecilia Rodriguez Lanzi; Verónica C Soto; Diahann J Perdicaro; Claudio R Galmarini; Fawaz G Haj; Roberto M Miatello; Patricia I Oteiza
Journal:  Mol Nutr Food Res       Date:  2015-03-11       Impact factor: 5.914

2.  A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of STA-2 (Green Tea Polyphenols) in Patients with Chronic Stable Angina.

Authors:  Tsung-Ming Lee; Min-Ji Charng; Chuen-Den Tseng; Ling-Ping Lai
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

3.  Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.

Authors:  A Ukil; S Maity; P K Das
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

4.  Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Michele Spina; Chi Nhan Tran; Maurizio Falconi; Anna Maria Eleuteri; Mauro Angeletti
Journal:  J Lipid Res       Date:  2011-02-25       Impact factor: 5.922

Review 5.  Weight control and prevention of metabolic syndrome by green tea.

Authors:  Sudathip Sae-tan; Kimberly A Grove; Joshua D Lambert
Journal:  Pharmacol Res       Date:  2010-12-28       Impact factor: 7.658

6.  Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.

Authors:  Fadi Annaba; Pradeep Kumar; Amish K Dudeja; Seema Saksena; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-07       Impact factor: 4.052

7.  Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects.

Authors:  Rong-Rong He; Ling Chen; Bing-Hui Lin; Yokichi Matsui; Xin-Sheng Yao; Hiroshi Kurihara
Journal:  Chin J Integr Med       Date:  2009-03-07       Impact factor: 1.978

8.  Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases.

Authors:  K Imai; K Nakachi
Journal:  BMJ       Date:  1995-03-18

Review 9.  Potential therapeutic properties of green tea polyphenols in Parkinson's disease.

Authors:  Tianhong Pan; Joseph Jankovic; Weidong Le
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Does regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression.

Authors:  D Neves; M Assunção; F Marques; J P Andrade; H Almeida
Journal:  Age (Dordr)       Date:  2008-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.